News
February 28, 2020

Regenstrief researcher leads Scottsdale webinar on hypoglycemia findings

Regenstrief Institute research scientist Michael Weiner, M.D., MPH, led a Scottsdale Institute webinar and presented his recent research findings related to hypoglycemia.

Dr. Weiner explained the statistical modeling that identified the magnitude of risk factors for hypoglycemia. He also discussed a pilot study using continuous glucometers and other wearable devices designed to make better predictions of glucose levels in older adults with diabetes who live in urban areas.

Dr. Weiner’s overall research focuses on measuring and improving the quality, coordination and delivery of health services for older adults. His research has included projects addressing hypoglycemia, a condition characterized by a low level of blood sugar and often related to the treatment of diabetes, along with personal habits. It can cause symptoms that include cognitive impairment and is also a risk factor for dementia.

The Scottsdale Institute is a not-for-profit membership organization of prominent healthcare systems. The institute’s goal is to support its members as they work to achieve clinical integration and transformation through information technology. The Scottsdale Institute provides forums, such as teleconferences, to promote collaboration, education and networking.

In addition to his role as a research scientist at Regenstrief, Dr. Weiner is an associate director of the William M. Tierney Center for Health Services Research at Regenstrief, director of the Veterans Affairs Health Services Research and Development Center for Health Information and Communication, and a professor of medicine at Indiana University School of Medicine.

More information on Dr. Weiner’s research.

  • Dr. Michael Weiner

Related News

Researchers to study online therapy’s potential to prevent cognitive decline in ICU survivors

Researchers to study online therapy’s potential to prevent cognitive decline in ICU survivors

Indianapolis – Researchers from Indiana University Indianapolis, Regenstrief Institute and the IU School of Medicine’s Indiana Alzheimer’s Disease Research

Malaz Boustani, M.D., MPH, Paul Dexter, M.D., Zina Ben Miled, PhD, M.S.

Dementia risk prediction: Zero-minute assessment at less than a dollar cost

Risk detection is important for care management and may alter course of the disease INDIANAPOLIS – A new study

Joshua Vest, PhD, MPH

Regenstrief Institute researcher appointed associate dean for research at IU Indianapolis Fairbanks School of Public Health

Regenstrief Institute Research Scientist Joshua Vest, PhD, MPH, has been appointed associate dean for research at the Indiana University

Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation

Title: Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation Published in the journal JAMA Neurology. Here is